Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
Conference Overview
The 43rd Pharmacovigilance India 2026 brings together regulatory officials, pharmaceutical leaders, and drug safety experts to examine emerging trends in safety surveillance and compliance. As India’s life sciences market grows rapidly, this event focuses on modernizing systems to ensure drug safety across global healthcare channels. The agenda delivers strategic guidance for implementing technological, operational, and regulatory advancements.
AI & Automation
Explore how artificial intelligence, machine learning, and automated literature screening are transforming signal detection and drug safety workflows. Discussions center on utilizing technology to transition toward continuous risk intelligence.
PV Outsourcing
Address strategic operational frameworks that effectively balance efficiency, high quality, and strict regulatory compliance. Panels evaluate India’s expanding role as a global hub for specialized pharmacovigilance services.
Risk Management
Reimagine risk management plans (RMPs) and risk evaluation frameworks to make sounder benefit-risk decisions. Sessions share actionable practices for maintaining safety throughout a drug’s lifecycle.
Real-World Evidence
Discover practical strategies for integrating Real-World Data (RWD) and Real-World Evidence (RWE) into safety monitoring systems. Experts demonstrate how observational data can enhance signal evaluation and patient outcomes.
Regulatory Harmonization
Examine evolving global compliance guidelines, combination product safety, and closer collaboration between industry and regulators. Speakers discuss frameworks that support innovative safety oversight.
Audit Readiness
Focus on vendor oversight, moving from effective CAPAs to a culture of compliance. Discussions outline predictive inspection strategies to address quality risks before formal findings occur.
Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
43rd Pharmacovigilance India 2026: Shaping the Future of Drug Safety
Welcome to Virtue Insight’s 43rd Pharmacovigilance India 2026, held on november 18-19, 2026, at the Kohinoor Continental, Hotel Mumbai. As India’s pharmaceutical sector expands globally, maintaining robust safety surveillance is critical. This premier event brings together industry leaders, CROs, and regulatory experts to discuss key developments transforming drug safety. Key focus areas include AI-driven signal detection, automation, real-world evidence (RWE), risk management, and regulatory compliance. Designed for interactive discussion and peer-level networking, the conference offers essential insights into modernizing pharmacovigilance practices, optimizing outsourcing strategies, and strengthening patient safety standards across the global healthcare ecosystem
Speakers
Attendees
Hrs NETWORKING
SESSIONS
OUR ATTENDEES
Trusted by Industry Leaders Worldwide
REGISTER ATTEND LEARN NETWORK SUCCEED
5 reasons to attend the events
The 43rd Pharmacovigilance India 2026 brings together regulatory officials, pharmaceutical leaders, and safety experts to explore critical advancements in drug safety surveillance. As India's life sciences market continues to expand rapidly, the forum delivers strategic guidance for modernizing safety systems, scaling compliance, and optimizing technology. Attendees gain actionable perspectives on managing risk, elevating operational quality, and improving patient outcomes globally.
Elite Networking
Connect directly with senior-level decision-makers and C-suite leaders from global pharmaceutical powerhouses. Engage in discussion-driven sessions designed to build strategic, high-value industry partnerships
AI Integration
Explore how intelligent automation, machine learning, and AI are reshaping drug safety workflows. Learn how human-AI collaboration transitions operations toward continuous, real-time risk intelligence.
Regulatory Mastery
Gain up-to-date insights on global regulatory changes, combination products, and device compliance. Discover strategies to align with international regulatory expectations and maintain continuous inspection readiness.
Strategic Outsourcing
Evaluate modern outsourcing models that effectively balance operational efficiency with rigorous quality standards. Understand how to leverage India's expanding capabilities as a reliable global pharmacovigilance hub.
Data-Driven Safety
Discover practical approaches for integrating Real-World Evidence (RWE) and Real-World Data (RWD) into core safety workflows. Learn to utilize observational data to refine risk management plans and enhance patient outcomes.
Meet Our Expert Speakers
OUR EVENT SCHEDULE
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:20 – Welcome Address
MARKET TRENDS
09:30 – Pharmacovigilance Journey – Schedule Y and Beyond
• The Foundation: The Era of Schedule Y
• The Paradigm Shift: Pharmacovigilance Programme of India
• Beyond Schedule Y: NDCT Rules 2019
• Current PV Framework & Global Harmonization
APARNA PRABHUNE
Wockhardt
FUTURE OF PV – SAFETY CHALLENGES
10:00 – Keynote Panel Discussion: Future-Proofing Pharmacovigilance: Navigating data complexity, accelerated approvals, and emerging safety challenges in modern drug surveillance.
Moderator
MURTUZA BUGHEDIWALA
Neovation Consultancy Services
Panellists
INDU NAMBIAR
Sanofi Consumer Healthcare India
JYOTSNA PATWARDHAN
Novartis
KUSHAL SARDA
Alkem Laboratories
PRIYA PRASAD
Lupin
10:50 – Morning Coffee/Tea & Networking
PATIENT VOICE & ADR REPORTING
11:20 – Panel Discussion: Patient-Centric Pharmacovigilance: Strengthening drug safety through patient engagement, inclusivity, and real-world reporting
Moderator
VISHWAS SOVANI
Pharmawisdom
Panellists
JAMAL BAIG
MSD
ANJU AGARWA
Advanz Pharma
SOURABH FULMALI
Sanofi
JYOTI KASHID
Lundbeck
12:10 - Topic TBC
Speaker TBC
12:50 – Networking luncheon
OUTSOURCING MODELS & SCALABILITY
13:50 – Panel Discussion: Strategic PV Outsourcing: Scaling pharmacovigilance operations through smarter partnerships, expertise, and global delivery models.
Moderator
Panellists
PRASAD DESHMUKH
Cipla
RAHUL SOMANI
Alkem Laboratories
SAFETY – SIGNAL DETECTION
14:40 - Quality, Safety & Signal Detection – Best practice
· Developing a global safety intelligence process
· Exploring patient support and marketing research programs from a safety perspective
· Statistical signal detection as a routine pharmacovigilance practice
· Moving towards a better future: bigger and better
· Lessons to be learned towards vaccine related to signal detection and evaluation
· Case studies
15:10 – Afternoon Tea/Coffee & Networking
15:40 – Safety - Signal Detection
Automation in Pharmacovigilance: A Closer look at use cases
· Key Use Cases of Automation in Pharmacovigilance
· Robotic process automation (RPA), AI, Machine Learning
· Which areas of PV are you most likely to automate?
· Cognitive Computing in Pharmacovigilance: Revamping Drug Safety Using an Advanced Computing System
· Building an Automation-Centric Approach to Drug Safety
RMPs, MITIGATION, STRUCTURED RISK STRATEGIES
16:10 – Panel Discussion - Next-Generation Risk Management: Building proactive, sustainable, and benefit-risk driven pharmacovigilance frameworks
Moderator
DILIP PAWAR
BDR Pharma
Panellists
KISHORE DARISI
GSK
ASHISH BHANDARKAR
Clinevo Technologies
SHREYA DESHPANDE Novartis
Novartis
DEEPTI JARANDE
(Division of J&J)
ASHISH BHANDARKAR
Clinevo Technologies
SHREYA DESHPANDE Novartis
Novartis
17:00 – Closing remarks and end of conference
14:50 - Re-imagining Dossier Authoring: From Manual Compilation to AI-Assisted Authoring and Lifecycle Management
- AI-driven automation in dossier creation: Transition from time-consuming manual compilation to intelligent automation where AI tools structure, draft, and validate regulatory dossiers using pre-designed templates as per ICH guidelines and real-time data processing.
- Enhanced compliance and efficiency: AI-assisted authoring ensures alignment with global regulatory standards (e.g., EMA, USFDA, CDSCO) by auto-updating changes in guidance and improving accuracy, traceability, and submission timelines.
- Lifecycle intelligence and version management: Integrating AI into the dossier lifecycle enables continuous monitoring, smart version control, and predictive updates across product changes, fostering a fully connected regulatory ecosystem.
MANASA KASIVAJJULA
CEO and Co-Founder
DeepForrest.ai (A CtrlS Company)
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues
BEYOND COMPLIANCE
09:30 - Beyond Compliance: How Local Pharmacovigilance Teams Can Drive Real Patient Safety Impact
· Evolution of local PV responsibilities
· Moving beyond metrics
· Identifying local safety signals and emerging risks and patient insights
· Collaboration with medical, regulatory, quality and commercial teams
· Building a patient-centric safety culture
ANUJA JAWALE
Kenvue (Division of J&J)
TECHNOLOGY, AUTOMOATION, DIGITAL ECOSYSTEMS
10:00 – Keynote Panel Discussion - Digital Pharmacovigilance Transformation: Harnessing AI, big data, and connected ecosystems for intelligent safety surveillance.
Moderator
MANGALA KOTNIS
Kenvue (Division of J&J)
Panellists
SUCHITA MORE
MSD
SAKSHI SHRIVASTAVA DESAI
Johnson & Johnson
KABIL KALATHINGAL
Fresenius Kabi
TEJPAVAN PULA
Haleon
10:50 – Morning Coffee/Tea & Networking
AUDITS & INSPECTIONS READINESS
11:20 – Panel Discussion – Audit & Inspection Excellence: Strengthening pharmacovigilance systems for compliance, resilience, and regulatory preparedness.
Moderator
OMPRAKASH SADHWANI
FDA (Maharashtra State)
Panellists
RAGHUNANDAN SINGH
Advanz Pharma
MOHIT TRIVEDI
Sanofi
ROHAN SHINDE
JAMP India Pharmaceuticals
SELVAKUMAR S
Apotex
VRUNDA PANDYA
Sun Pharma
12:10 - Topic TBC
12:40 – Networking luncheon
RWD / RWE
13:50 – Panel Discussion - Leveraging Real-World Data & Evidence: Enhancing pharmacovigilance insights, benefit-risk decisions, and patient-centric outcomes.
Moderator
PRATIK SHAH
Bharat Serums and Vaccines
SANTOSH TAUR
Pfizer
KRUNAL DALAL
GSK
PANKAJ THAKUR
Hetero
PV UNSCRIPTED: ASK THE EXPERTS
14:40 – Ask the Experts: Cross-Functional PV Open Forum
A dynamic and highly interactive session designed to break away from the traditional panel format, this open forum brings together leading pharmacovigilance experts across key domains including digital transformation, outsourcing, regulatory affairs, audits & inspections, risk management, quality, patient safety and RWE. Instead of a moderated discussion among panelists, the session will be entirely driven by the audience, offering delegates the opportunity to raise real-world challenges, ask pressing questions, and gain practical insights directly from specialists in their respective fields. This unique format encourages spontaneous knowledge-sharing, honest perspectives, and solution-oriented dialogue, making it one of the most engaging and valuable sessions of the conference.
Speakers
RAJENDRA KUMAR KASI
Glenmark
ROHINI PANDEY
Abbott
RISHI JAIN
Novartis
SAKHARAM GARALE
Renovare Healthcare
KAVITA LAMROR
Maxis Clinical Sciences
MUGDHA SHAH
Sanofi
15:20 – Afternoon Tea/Coffee & Networking
REGULATORY REFORMS & SUBMISSIONS
15:50 - Panel Discussion – Evolving Pharmacovigilance Regulations: Adapting to global reforms, compliance shifts, and future safety governance.
Moderator
Panellists
KHOKAN DEBNATH
Wockhardt
DEVANG PATEL
Zydus Group
CHETAN PATIL
Piramal
SUSHMITA KUSWA
Piramal
DEVANG PATEL
Zydus Group
SUSHMITA KUSWA
Piramal
16:40 – Closing remarks & end of conference
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Our Partners
We sincerely thank the following organizations and individuals for generously contributing their time, financial support, ideas, and dedication toward the successful conduct of the 42nd pharmacovigilance india 2026
Principal Partner
Exhibitors
Event Venue
Kohinoor Continental Hotel
Mumbai
India
022 6769 3500
Get Involved
Networking App
Kindly Note!
Access to view and connect with other attendees through our mobile app will be enabled closer to the conference date.
Super Early Bird Price - valid till 30th Sep 2026
cost per delegate - fee 12,000 + GST per delegate
You can simply email or call and book your conference delegate seats on:
TEL: + 91 44 4210 8101 (or) Email — info@virtueinsight.com
Accommodation
We have secured special room rates for our conference participants who wish to stay at the conference venue hotel “Radisson” during the conference dates.
Once you confirm your participation, our operations team will share the room reservation details along with the booking deadline and the special rates we’ve arranged.
Event Testimonials
United Kingdom
Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK
Asia
Plot No – 07 – 2nd Floor
Ekambaram Industrial Estate
Alapakkam, Porur Chennai,
India – 600 116
Download App
